SCNI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Scinai Immunotherapeutics Ltd (SCNI) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The stock lacks positive momentum, has weak financial performance, and no significant catalysts or trading signals to justify an immediate purchase.
The technical indicators suggest a bearish trend. The MACD is negative and expanding downward, RSI is neutral, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with a pre-market price of 0.75, which is below S1 (0.776).
NULL identified. No recent news or significant trading activity from insiders or hedge funds.
Weak financial performance with declining net income (-4.29% YoY) and EPS (-100% YoY). Gross margin remains negative (-164.29%). Technical indicators are bearish, and there are no recent congress trades or influential figure activity.
In Q4 2024, revenue remained stagnant (0.00% YoY), net income dropped to -2,230,000 (-4.29% YoY), and EPS fell to 0 (-100% YoY). Gross margin is negative at -164.29%, showing no improvement.
No analyst ratings or price target changes available for SCNI.
